| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48657190A | 1990-02-28 | 1990-02-28 | |
| US486,571 | 1990-02-28 |
| Publication Number | Publication Date |
|---|---|
| WO1991013160A1true WO1991013160A1 (fr) | 1991-09-05 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1991/001078WO1991013160A1 (fr) | 1990-02-28 | 1991-02-26 | Vecteurs d'expressions de cellules de mammiferes |
| Country | Link |
|---|---|
| EP (1) | EP0517768A1 (fr) |
| JP (1) | JPH05503015A (fr) |
| AU (1) | AU7444191A (fr) |
| CA (1) | CA2076975A1 (fr) |
| WO (1) | WO1991013160A1 (fr) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992008792A3 (fr)* | 1990-11-16 | 1992-07-23 | Schering Corp | PROCEDE D'AUGMENTATION ET D'ACTIVATION DES MONOCYTES ET DES NEUTROPHILES ET D'INDUCTION DE LA MATURATION DE CELLULES MYELOïDES A L'AIDES DE L'INTERLEUKINE-5 |
| EP0732404A4 (fr)* | 1993-12-03 | 1997-07-30 | Asahi Chemical Ind | Nouveau vecteur de detection d'expression |
| EP0982398A1 (fr)* | 1995-03-20 | 2000-03-01 | The Regents Of The University Of California | Acides nucléiques et leurs utilisation pour la détermination de beta-lactamase |
| EP1143006A3 (fr)* | 1996-08-19 | 2003-12-17 | MorphoSys IP GmbH | Vecteurs/DNA-séquences provenant de banques d'anticorps humaines |
| WO2004070030A1 (fr)* | 2003-02-03 | 2004-08-19 | Immuno Japan Inc. | Vecteur de surexpression pour une cellule animale |
| WO2005017148A1 (fr) | 2003-07-26 | 2005-02-24 | Trubion Pharmaceuticals, Inc. | Constructions de liaison et procedes d'utilisation correspondants |
| US7326567B2 (en) | 2003-11-12 | 2008-02-05 | Schering Corporation | Plasmid system for multigene expression |
| WO2010062697A2 (fr) | 2008-10-30 | 2010-06-03 | Peixuan Guo | Biocapteur à connecteur de protéine motrice d'encapsulation d'adn viral à intégration membranaire pour séquençage d'adn et autres utilisations |
| EP2316951A1 (fr) | 2001-01-17 | 2011-05-04 | Trubion Pharmaceuticals, Inc. | Proteines de fusion d'immunoglobuline de domaine de liaison |
| US8017735B2 (en) | 2003-11-21 | 2011-09-13 | Schering Corporation | Anti-IGFR1 antibody therapeutic combinations |
| US8137933B2 (en) | 2008-11-12 | 2012-03-20 | Schering Corporation | Mammalian expression vector pUHAB |
| US9017679B2 (en) | 2005-08-30 | 2015-04-28 | University Of Miami | Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins |
| EP3061462A1 (fr) | 2007-07-02 | 2016-08-31 | Etubics Corporation | Procédés et compositions permettant de produire un vecteur d'adénovirus destiné à être utilisé avec des vaccinations multiples |
| US9499627B2 (en) | 2009-08-03 | 2016-11-22 | University Of Miami | Method for in vivo expansion of T regulatory cells |
| US9605276B2 (en) | 2012-08-24 | 2017-03-28 | Etubics Corporation | Replication defective adenovirus vector in vaccination |
| US9603925B2 (en) | 2013-01-09 | 2017-03-28 | University Of Miami | Compositions comprising TL1A-Ig fusion protein for the regulation of T regulatory cells, and methods for their use |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4656134A (en)* | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
| EP0276730A2 (fr)* | 1987-01-24 | 1988-08-03 | BEHRINGWERKE Aktiengesellschaft | Système de vecteur en forme de cassette pour l'expression d'une structure à lecture ouverte dans des cellules eucariotes |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8629153D0 (en)* | 1986-12-05 | 1987-01-14 | Ciba Geigy Ag | Hybrid proteins |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4656134A (en)* | 1982-01-11 | 1987-04-07 | Board Of Trustees Of Leland Stanford Jr. University | Gene amplification in eukaryotic cells |
| EP0276730A2 (fr)* | 1987-01-24 | 1988-08-03 | BEHRINGWERKE Aktiengesellschaft | Système de vecteur en forme de cassette pour l'expression d'une structure à lecture ouverte dans des cellules eucariotes |
| Title |
|---|
| Gene, volume 71, no. 1, 15 November 1988, Elsevier Science Publishers B.V., (Amsterdam, NL), H. Ikeda et al.: "Mulcos: a vector for amplification and simultaneous expression of two foreign genes in mammalian cells", 19-27* |
| Journal of Molecular and Applied Genetics, volume 2, no. 1, 1983, Raven, (New York, US), C.V. Hall et al.: "Expression and regulation of escherichia coli lac z gene fusions in mammalian cells", pages 101-109* |
| Molecular and Cellular Biology, volume 2, no. 9, 1982, American Society for Microbiology, (US), C.M. Corman et al.: "Recombinant genomes which express chloraphenicol acetyltransferase in mammalian cells" pages 1044-1051* |
| Molecular and Cellular Biology, volume 8, no. 1, 1988, (US), Y. Takebe et al.: "SRx promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat", pages 466-472* |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992008792A3 (fr)* | 1990-11-16 | 1992-07-23 | Schering Corp | PROCEDE D'AUGMENTATION ET D'ACTIVATION DES MONOCYTES ET DES NEUTROPHILES ET D'INDUCTION DE LA MATURATION DE CELLULES MYELOïDES A L'AIDES DE L'INTERLEUKINE-5 |
| US6214613B1 (en) | 1993-12-03 | 2001-04-10 | Ashai Kasei Kogyo Kabushiki Kaisha | Expression screening vector |
| EP0732404A4 (fr)* | 1993-12-03 | 1997-07-30 | Asahi Chemical Ind | Nouveau vecteur de detection d'expression |
| US6291162B1 (en) | 1995-03-20 | 2001-09-18 | The Regents Of The University Of California | Cytosolic forms of beta-lactamase and uses thereof |
| US7157575B2 (en) | 1995-03-20 | 2007-01-02 | The Regents Of The University Of California | Substrates for β-lactamase and uses thereof |
| US6472205B1 (en) | 1995-03-20 | 2002-10-29 | The Regents Of The University Of California | Cytosolic forms for β-lactamase and uses thereof |
| US8071761B2 (en) | 1995-03-20 | 2011-12-06 | The Regents Of The University Of California | Substrates for beta-lactamase and uses thereof |
| EP1405922A3 (fr)* | 1995-03-20 | 2004-09-29 | The Regents of the University of California | Substrats pour beta-lactamase et utilisations de ces substrats |
| EP0982398A1 (fr)* | 1995-03-20 | 2000-03-01 | The Regents Of The University Of California | Acides nucléiques et leurs utilisation pour la détermination de beta-lactamase |
| EP1143006A3 (fr)* | 1996-08-19 | 2003-12-17 | MorphoSys IP GmbH | Vecteurs/DNA-séquences provenant de banques d'anticorps humaines |
| EP2316951A1 (fr) | 2001-01-17 | 2011-05-04 | Trubion Pharmaceuticals, Inc. | Proteines de fusion d'immunoglobuline de domaine de liaison |
| EP2706116A1 (fr) | 2001-01-17 | 2014-03-12 | Emergent Product Development Seattle, LLC | Proteines de fusion d'immunoglobuline de domaine de liaison |
| WO2004070030A1 (fr)* | 2003-02-03 | 2004-08-19 | Immuno Japan Inc. | Vecteur de surexpression pour une cellule animale |
| WO2005017148A1 (fr) | 2003-07-26 | 2005-02-24 | Trubion Pharmaceuticals, Inc. | Constructions de liaison et procedes d'utilisation correspondants |
| US7326567B2 (en) | 2003-11-12 | 2008-02-05 | Schering Corporation | Plasmid system for multigene expression |
| US8062886B2 (en) | 2003-11-12 | 2011-11-22 | Schering Corporation | Plasmid system for multigene expression |
| US8017735B2 (en) | 2003-11-21 | 2011-09-13 | Schering Corporation | Anti-IGFR1 antibody therapeutic combinations |
| US9017679B2 (en) | 2005-08-30 | 2015-04-28 | University Of Miami | Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins |
| US11395846B2 (en) | 2005-08-30 | 2022-07-26 | University Of Miami | Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins |
| US9839670B2 (en) | 2005-08-30 | 2017-12-12 | University Of Miami | Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists, and immunotoxins |
| US11504423B2 (en) | 2007-07-02 | 2022-11-22 | Etubics Corporation | Methods and compositions for producing an adenovirus vector for use with multiple vaccinations |
| EP3061462A1 (fr) | 2007-07-02 | 2016-08-31 | Etubics Corporation | Procédés et compositions permettant de produire un vecteur d'adénovirus destiné à être utilisé avec des vaccinations multiples |
| US11826417B2 (en) | 2007-07-02 | 2023-11-28 | Etubics Corporation | Methods and compositions for producing an adenovirus vector for use with multiple vaccinations |
| US11529408B2 (en) | 2007-07-02 | 2022-12-20 | Etubics Corporation | Methods and compositions for producing an adenovirus vector for use with multiple vaccinations |
| US11344613B2 (en) | 2007-07-02 | 2022-05-31 | Etubics Corporation | Sequential administration of a replication defective adenovirus vector in vaccination protocols |
| US12370250B2 (en) | 2007-07-02 | 2025-07-29 | Etubics Corporation | Methods and compositions for producing an adenovirus vector for use with multiple vaccinations |
| EP3539567A1 (fr) | 2007-07-02 | 2019-09-18 | Etubics Corporation | Procédés et compositions permettant de produire un vecteur d'adénovirus destiné à être utilisé avec des vaccinations multiples |
| US11389521B2 (en) | 2007-07-02 | 2022-07-19 | Etubics Corporation | Methods and compositions for producing an adenovirus vector for use with multiple vaccinations |
| US11376316B2 (en) | 2007-07-02 | 2022-07-05 | Etubics Corporation | Breast cancer vaccines and methods of use thereof |
| US11369673B2 (en) | 2007-07-02 | 2022-06-28 | Etubics Corporation | HPV vaccines and methods of use thereof |
| WO2010062697A2 (fr) | 2008-10-30 | 2010-06-03 | Peixuan Guo | Biocapteur à connecteur de protéine motrice d'encapsulation d'adn viral à intégration membranaire pour séquençage d'adn et autres utilisations |
| US9528125B2 (en) | 2008-11-12 | 2016-12-27 | Merck Sharp & Dohme Corp. | Mammalian expression vector pUHAB |
| US8137933B2 (en) | 2008-11-12 | 2012-03-20 | Schering Corporation | Mammalian expression vector pUHAB |
| US8951790B2 (en) | 2008-11-12 | 2015-02-10 | Merck Sharp & Dohme Corp. | Mammalian expression vector pUHAB |
| US10934364B2 (en) | 2009-08-03 | 2021-03-02 | University Of Miami | Method for in vivo expansion of T regulatory cells |
| US9499627B2 (en) | 2009-08-03 | 2016-11-22 | University Of Miami | Method for in vivo expansion of T regulatory cells |
| US10563224B2 (en) | 2012-08-24 | 2020-02-18 | Etubics Corporation | Replication defective adenovirus vector in vaccination |
| US9605276B2 (en) | 2012-08-24 | 2017-03-28 | Etubics Corporation | Replication defective adenovirus vector in vaccination |
| USRE48599E1 (en) | 2013-01-09 | 2021-06-22 | University Of Miami | Compositions comprising TLIA-Ig fusion protein for the regulation of T regulatory cells, and methods for their use |
| US9603925B2 (en) | 2013-01-09 | 2017-03-28 | University Of Miami | Compositions comprising TL1A-Ig fusion protein for the regulation of T regulatory cells, and methods for their use |
| Publication number | Publication date |
|---|---|
| EP0517768A1 (fr) | 1992-12-16 |
| AU7444191A (en) | 1991-09-18 |
| CA2076975A1 (fr) | 1991-08-29 |
| JPH05503015A (ja) | 1993-05-27 |
| Publication | Publication Date | Title |
|---|---|---|
| EP0173552B1 (fr) | Composés recombinants d'ADN et l'expression de polypeptides comme le tPA | |
| CA1301675C (fr) | Construction d'un vecteur d'expression polycistronique | |
| Chen et al. | High-efficiency transformation of mammalian cells by plasmid DNA | |
| US4601978A (en) | Mammalian metallothionein promoter system | |
| US5981214A (en) | Production of proteins using homologous recombination | |
| US4935363A (en) | Sterol regulatory elements | |
| WO1991013160A1 (fr) | Vecteurs d'expressions de cellules de mammiferes | |
| HU208711B (en) | Method for preparing gm-csf and transformation vector containing csf/cdna, also a methold for purifying the csf protein | |
| EP0724639B1 (fr) | Procedes pour la selection de cellules hotes de recombinaison exprimant des niveaux eleves d'une proteine desiree | |
| US4965196A (en) | Polycistronic expression vector construction | |
| US5378603A (en) | Method and composition for identifying substances which activate transcription of the LDL receptor gene | |
| US5486462A (en) | Differentiative expression modules | |
| JP2001511342A (ja) | 内因性遺伝子の活性化によるヒト蛋白質の生産のためのヒト細胞株の同定 | |
| Reddy et al. | Nonselective expression of simian virus 40 large tumor antigen fragments in mouse cells. | |
| JP2693361B2 (ja) | 組織プラスミノーゲン活性化因子の生産方法 | |
| WO1988000975A1 (fr) | Expression de genes heterologues pouvant etre induite a un haut niveau | |
| WO1987005935A1 (fr) | Procedes et compositions d'expression de produits genetiques eucaryotiques competitifs | |
| US5215910A (en) | Host cells transformed with sterol regulatory elements | |
| US5646010A (en) | Methods and compositions for expression of competent eukaryotic gene products | |
| AU602664B2 (en) | DNA sequence containing the DNA sequence coding for human tissue plasminogen activator originating from human normal cells, recombinant DNA incorporating the DNA sequence, host cells transformed with the recombinant DNA, and process for producing human tissue plasminogen activator by use of the host cells | |
| US4889802A (en) | Enhanced production of recombinant proteins in myeloma cells | |
| EP0198386A2 (fr) | Production maintenue à un haut niveau de gamma-interféron humain recombinant par l'utilisation du papillomavirus bovin | |
| JP2826114B2 (ja) | 遺伝子産物の製法 | |
| EA010059B1 (ru) | Flp-опосредованная рекомбинация | |
| NO845186L (no) | Vektorsystem for innfoering av heterolog dna i eykaryotiske celler. |
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states | Kind code of ref document:A1 Designated state(s):AU BB BG BR CA FI HU JP KP KR LK MC MG MW NO RO SD SU US | |
| AL | Designated countries for regional patents | Kind code of ref document:A1 Designated state(s):AT BE BF BJ CF CG CH CM DE DK ES FR GA GB GR IT LU ML MR NL SE SN TD TG | |
| WWE | Wipo information: entry into national phase | Ref document number:1991905143 Country of ref document:EP | |
| WWE | Wipo information: entry into national phase | Ref document number:2076975 Country of ref document:CA | |
| WWP | Wipo information: published in national office | Ref document number:1991905143 Country of ref document:EP | |
| WWW | Wipo information: withdrawn in national office | Ref document number:1991905143 Country of ref document:EP |